| | SA | Mild/mod asthma | p |
|---|
| N | 94 | 47 | |
| Female (%) | 46 (49) | 16 (34) | 0.11 |
| Age‚ years (IQR) | 13.0 (10.8–14.0) | 12.0 (9.0–14.0) | 0.09 |
| Atopic (%) n=122 | 70 (86.4) | 34 (82.9) | 0.60 |
| % FEV1(SD) | 89.0 (20.3) | 91.5 (16.7) | 0.45 |
| FENO (IQR) | 38.0 (14.2–62.5) | 24.5 (13.0–39.0) | 0.08 |
| ACT or CACT≤19 | 67 (72.0) | 15 (32.6) | <0.0001 |
| PAQLQ PACQLQ | 4.9 (3.5–6.1) | 6.0 (5.2–6.8) | <0.0001 |
| Exacerbations in past year(IQR) | 3.5 (2–5) | 0 (0–2) | <0.0001 |
| | SPSW | Mild/mod PSW | p |
|---|
| N | 80 | 51 | |
| Female (%) | 29 (36.3) | 18 (35.3) | 1.00 |
| Age years (IQR) | 4 (3–5) | 4 (3–4) | 0.70 |
| Atopic (%) n=111 | 29 (41.4) | 18 (39.1) | 0.85 |
| Body mass index (IQR) | 16.2 (17.93–24.60) | 16.02 (15.13–16.57) | 0.20 |
| CACT≤19 n=63 | 34 (77.2) | 4 (19.0) | <0.0001 |
| PACQLQ (IQR) | 4.4 (2.9–5.7) | 6.8 (5.5–7.0) | <0.0001 |
| Exacerbations in past year (IQR) | 4 (1.25–6) | 1 (0–2) | <0.0001 |